Publication | Closed Access

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial

Breast OncologyOncologyMedicineAdjuvant CapecitabineClinical TrialsBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacology